KMT2C and breast carcinoma: Interestingly, data from several large-scale cancer sequencing studies have identified KMT2C (also referred to as MLL3), which encodes an H3K4 histone methyltransferase, as one of the most commonly mutated genes in breast cancer with a mutation frequency of approximately 8% [9–11].